Gregory Glenn

(Dr. Gregory Glenn M.D.)

Currently holds a position at Novavax Inc

Positions

Position Company Period
President, Research and Development Novavax Inc March 1, 2016 -
Senior Vice President - Research & Development Novavax Inc Jan. 13, 2014 - March 1, 2016
Senior Vice President, Chief Medical Officer Novavax Inc Jan. 1, 2011 - Jan. 13, 2014
Gregory Glenn's trades of Novavax Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-14 2023-03-10
US Novavax Inc (NVAX)
B Purchase
1,000 +7.4%
6.50
USD 6,500 		1,000 +7.4% 6.50 USD 6,500
2023-03-14 2023-03-07
US Novavax Inc (NVAX)
B Purchase
2,000 +17.4%
7.04
USD 14,088 		2,000 +17.4% 7.04 USD 14,088
2023-03-14 2023-03-06
US Novavax Inc (NVAX)
PP Planned purchase
3,000 +35.4%
7.48
USD 22,454 		3,000 +35.4% 7.48 USD 22,454
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
27 -0.5%
180.62
USD 4,877 		27 -0.5% 180.62 USD 4,877
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
206 -3.5%
179.58
USD 36,993 		206 -3.5% 179.58 USD 36,993
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
103 -1.7%
178.99
USD 18,436 		103 -1.7% 178.99 USD 18,436
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
223 -3.6%
176.83
USD 39,432 		223 -3.6% 176.83 USD 39,432
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
67 -1.1%
175.89
USD 11,785 		67 -1.1% 175.89 USD 11,785
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
137 -2.1%
174.65
USD 23,927 		137 -2.1% 174.65 USD 23,927
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
91 -1.4%
173.29
USD 15,770 		91 -1.4% 173.29 USD 15,770
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
248 -3.7%
172.38
USD 42,750 		248 -3.7% 172.38 USD 42,750
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
254 -3.6%
171.47
USD 43,553 		254 -3.6% 171.47 USD 43,553
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
213 -2.9%
170.46
USD 36,309 		213 -2.9% 170.46 USD 36,309
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PS Planned sale
117 -1.6%
168.82
USD 19,752 		117 -1.6% 168.82 USD 19,752
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
100 -2.4%
182.96
USD 18,296 		100 -2.4% 182.96 USD 18,296
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
853 -17.0%
182.30
USD 155,498 		853 -17.0% 182.30 USD 155,498
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
500 -9.1%
180.29
USD 90,147 		500 -9.1% 180.29 USD 90,147
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
500 -8.3%
179.36
USD 89,680 		500 -8.3% 179.36 USD 89,680
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
500 -7.7%
178.21
USD 89,104 		500 -7.7% 178.21 USD 89,104
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
800 -10.9%
176.20
USD 140,956 		800 -10.9% 176.20 USD 140,956
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
900 -11.0%
175.13
USD 157,619 		900 -11.0% 175.13 USD 157,619
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
200 -2.4%
173.14
USD 34,627 		200 -2.4% 173.14 USD 34,627
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
200 -2.3%
171.30
USD 34,260 		200 -2.3% 171.30 USD 34,260
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
400 -4.4%
168.77
USD 67,508 		400 -4.4% 168.77 USD 67,508
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
300 -3.2%
167.06
USD 50,118 		300 -3.2% 167.06 USD 50,118
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
300 -3.1%
165.80
USD 49,739 		300 -3.1% 165.80 USD 49,739
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
300 -3.0%
164.77
USD 49,430 		300 -3.0% 164.77 USD 49,430
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
200 -2.0%
162.83
USD 32,565 		200 -2.0% 162.83 USD 32,565
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
300 -2.9%
161.63
USD 48,490 		300 -2.9% 161.63 USD 48,490
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
300 -2.8%
160.52
USD 48,157 		300 -2.8% 160.52 USD 48,157
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
300 -2.7%
158.42
USD 47,527 		300 -2.7% 158.42 USD 47,527
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
200 -1.8%
157.02
USD 31,404 		200 -1.8% 157.02 USD 31,404
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
300 -2.6%
156.24
USD 46,873 		300 -2.6% 156.24 USD 46,873
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
100 -0.9%
154.38
USD 15,438 		100 -0.9% 154.38 USD 15,438
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
397 -3.3%
153.53
USD 60,951 		397 -3.3% 153.53 USD 60,951
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
100 -0.8%
151.85
USD 15,185 		100 -0.8% 151.85 USD 15,185
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PS Planned sale
200 -1.6%
150.30
USD 30,059 		200 -1.6% 150.30 USD 30,059
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
100 -2.4%
211.75
USD 21,175 		100 -2.4% 211.75 USD 21,175
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
551 -11.7%
210.57
USD 116,026 		551 -11.7% 210.57 USD 116,026
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
879 -15.7%
209.81
USD 184,419 		879 -15.7% 209.81 USD 184,419
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
1,450 -20.6%
208.78
USD 302,727 		1,450 -20.6% 208.78 USD 302,727
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
353 -4.8%
207.19
USD 73,139 		353 -4.8% 207.19 USD 73,139
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
439 -5.6%
206.06
USD 90,462 		439 -5.6% 206.06 USD 90,462
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
465 -5.6%
203.79
USD 94,764 		465 -5.6% 203.79 USD 94,764
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PS Planned sale
715 -7.9%
202.37
USD 144,692 		715 -7.9% 202.37 USD 144,692
// ... existing code ...